Skip to main content

Stage 3 Lung Cancer

Cancer is uncontrolled growth of abnormal cells. Growth of abnormal cells in one or both lungs could be indicative of lung cancer. These abnormal cells have a tendency to grow but do not develop into healthy tissue of lungs. Research has shown that 87% of lung cancer is related to smoking. Risks are considerably reduced if the person quits smoking.

Extent to which cancer has spread is categorized as different stages. The stage depends upon the size of tumor and areas it has spread to. Doctors decide mode of treatment based on the stage of cancer.

Localized cancer in a particular part of lung is termed as Stage 1. If it has spread to the lymph nodes at the top of the lungs, it is termed as Stage 2. Cancer spreads to the chest walls during Stage 3. There is a possibility of cancer having spread to other parts of the body such as windpipe or heart, once it reaches Stage 3. Sometimes there can be fluid collection around the lungs that contain cancer cells.

Symptoms of lung cancer can vary from patient to patient. Common symptoms are continuous cough or formation of phlegm with signs of blood in it. More pronounced are symptoms such as a hoarse voice or difficulty in swallowing. Sometimes there is a swelling at the cancerous area.

Lung cancer can be treated in many ways such as surgery, radiotherapy or chemotherapy. Doctors determine treatment depending upon the stage cancer has reached. In initial stages, the patient can be treated by chemotherapy or radiotherapy. Usually surgery is recommended to remove malignant tumor found in stage 3-lung cancer. If this does not suffice, the doctors remove the lung to abate growth of cancer cells. Some patients are given a combination of treatments. Chemotherapy is administered before surgery for effective treatment.

It is very important to detect cancer in its earlier stages for effective treatment. As the cancer spreads, treatment becomes more complicated.

Popular posts from this blog

Who should get a CT scan to screen for lung cancer?

By Jenifer Goodwin HealthDay Reporter THURSDAY, June 30 (HealthDay News) -- Annual low-dose CT scans cut the death rate from lung cancer by 20% in heavy smokers and formerly heavy smokers, compared to those who get annual chest X-rays, according to the results of a major National Cancer Institute study released on Wednesday. Experts are calling the findings a major advance in efforts to combat lung cancer deaths. By catching the cancer early, the tumors can be removed surgically -- hopefully before they've spread and become very difficult to cure. "This is a momentous time in the history of public health research," said Dr. Otis Brawley, chief medical officer of the American Cancer Society. "The NLST [National Lung Screening Trial] is the best-designed and best-performed lung cancer screening study in history." Yet the findings raise as many questions as they answer, said Dr. Harold Sox, a professor emeritus of medicine at Dartmouth Medical School who wrote an...

Throat Cancer Survival Rate - Know Your Chances

If you haven't known yet, the throat cancer survival rate is usually based on each stage of the cancer. This really isn't surprising knowing that most cancer survival percentages are estimated by their stages. A throat cancer survival rate may be measured by 5 years or 10 years period. But recently, most researchers are now using the 5 years time period when conducting survival rate studies of most cancers. Cancer of the throat is the cancer of our voice box (larynx) and its surrounding tissues. The most prominent parts of our throat are the larynx and the pharynx but most cancers arise from the former, accounting to nearly half of all throat cancer cases in America. Statistical studies will tell you that in the us alone, more than 25,000 people are being diagnosed of this type of cancer per year. Smoking is one of the major predisposing factors of this cancer, therefore, the prevalence rate of acquiring this disease is higher in male than in female. As the person ages, the ch...

Analysis: Life saving lung cancer test to set off cost debate

By Bill Berkrot NEW YORK | Wed Jun 29, 2011 6:07pm EDT NEW YORK (Reuters) - A landmark study showing that routine lung screening of heavy smokers and former smokers using low dose CT scans could save thousands of lives is sure to set off a fierce debate about the cost of such testing on an overburdened healthcare system. The U.S. National Cancer Institute studied more than 53,000 people between the ages of 55 and 74 deemed at high risk of developing lung cancer. It found that screening with the three-dimensional X-rays cut deaths by 20 percent. Details of the study and a discussion of its implications were published on Wednesday in the New England Journal of Medicine, lending additional weight to initial findings that were released in November. The discussion noted that radiologists using more advanced CT equipment than was available for the study could lead to an even larger reduction in lung cancer deaths. At the same time, the potential for many more false positive results could ri...